Zacharias Isaac 的 Form 4/A 修正申報
修正Shockwave Medical, Inc.SWAV,2023/3/21 申報
- 申報編號
- 0001209191-23-020419
- 申報時間
- 2023/3/21
- 交易日
- 2022/12/27
- 申報延遲
- 84 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2022/12/28
這份申報列了 1 筆非衍生性交易。沿用原件裡沒有重述的 2 筆交易。公開市場賣出合計 $83.8 萬。交易後 84 天申報。
這份修正申報重述了 0001209191-22-062868(2022/12/28 申報)的一部分,沒有重述的交易仍然有效,列在下面。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Zacharias IsaacCIK 0001768265 | 高階主管(President, CCO) |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/27 | Common Stock | S賣出處分 | −4,000 | $209.59F2 | −$838,360 | 87,021 | 直接 |
沿用原件的交易
這份修正申報只重述了原件的一部分。原件其他的交易仍然有效,網站的交易表把它們算在這份修正申報底下。
來自 0001209191-22-062868(2022/12/28 申報)。
非衍生性證券(表 I)
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/27 | Common Stock | M行使選擇權取得 | +4,000 | $4.03 | +$16,120 | 77,021 | 直接 |
衍生性證券(表 II)
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/27 | Common Stock | M行使選擇權處分 | −4,000 | $0.00 | $0 | 5,222 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
The sale transaction reported here was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/25/2022, amended on 5/23/2022.
- F2
All reported securities were sold at a price of $209.59.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Twenty-Five percent of the shares subject to this option vested on 3/1/2019 and the balance of the shares vested in equal monthly installments thereafter for 36 months.
備註
The reporting person previously filed a Form 4 that erroneously reported the exercise of a stock option on December 27, 2022. Such exercise never, in fact, took place. This amendment is being filed to correct: (i) in Table II, Column 9, the number of options remaining on the reporting persons stock option as of December 27, 2022; and (ii) in Table I, Column 5, the number of shares of Common Stock the reporting person owned after the execution of the stock sale he completed on December 27, 2022, which sale was previously reported on the Form 4 amended hereby. Additionally, the reporting persons total in Table I, Column 5 has been corrected in this amendment to include 18,000 restricted stock units which were first awarded to the reporting person on February 1, 2021, but were inadvertently omitted from his total in certain prior Form 4 reports.